Stella Stergiopoulos

637 total citations
28 papers, 383 citations indexed

About

Stella Stergiopoulos is a scholar working on Economics and Econometrics, Statistics and Probability and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Stella Stergiopoulos has authored 28 papers receiving a total of 383 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Economics and Econometrics, 7 papers in Statistics and Probability and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Stella Stergiopoulos's work include Health Systems, Economic Evaluations, Quality of Life (9 papers), Statistical Methods in Clinical Trials (7 papers) and Pharmaceutical industry and healthcare (5 papers). Stella Stergiopoulos is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (9 papers), Statistical Methods in Clinical Trials (7 papers) and Pharmaceutical industry and healthcare (5 papers). Stella Stergiopoulos collaborates with scholars based in United States, Sweden and United Kingdom. Stella Stergiopoulos's co-authors include Kenneth Getz, Barbara Kunz, Kenneth I. Kaitin, Carrie Brown, Gustavo Grampp, Julian C. Desmond, Daniel Sheinson, Mark E. Fleury, Katherine T Lofgren and Mary B. Short and has published in prestigious journals such as Cancer Research, Clinical Infectious Diseases and Clinical Pharmacology & Therapeutics.

In The Last Decade

Stella Stergiopoulos

26 papers receiving 367 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stella Stergiopoulos United States 12 123 112 69 67 42 28 383
Alexandra Păcurariu Netherlands 12 136 1.1× 50 0.4× 184 2.7× 29 0.4× 43 1.0× 24 524
Tiffany S. Woodworth United States 8 73 0.6× 58 0.5× 49 0.7× 30 0.4× 22 0.5× 14 367
Susan Andrade United States 9 34 0.3× 96 0.9× 33 0.5× 36 0.5× 19 0.5× 12 519
Alex Asiimwe Germany 12 65 0.5× 89 0.8× 48 0.7× 40 0.6× 15 0.4× 27 355
Ana Hidalgo‐Simon Netherlands 9 99 0.8× 29 0.3× 69 1.0× 14 0.2× 54 1.3× 15 355
Stephanie D. Schech United States 8 99 0.8× 26 0.2× 62 0.9× 29 0.4× 13 0.3× 12 469
F. Maignen United Kingdom 9 116 0.9× 28 0.3× 125 1.8× 13 0.2× 35 0.8× 24 307
Janet Marchibroda United States 8 62 0.5× 79 0.7× 78 1.1× 142 2.1× 12 0.3× 13 468
Arun Bhatt United States 10 118 1.0× 184 1.6× 14 0.2× 95 1.4× 13 0.3× 29 393
Aarthi Iyer United States 10 81 0.7× 28 0.3× 61 0.9× 34 0.5× 14 0.3× 15 411

Countries citing papers authored by Stella Stergiopoulos

Since Specialization
Citations

This map shows the geographic impact of Stella Stergiopoulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stella Stergiopoulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stella Stergiopoulos more than expected).

Fields of papers citing papers by Stella Stergiopoulos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stella Stergiopoulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stella Stergiopoulos. The network helps show where Stella Stergiopoulos may publish in the future.

Co-authorship network of co-authors of Stella Stergiopoulos

This figure shows the co-authorship network connecting the top 25 collaborators of Stella Stergiopoulos. A scholar is included among the top collaborators of Stella Stergiopoulos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stella Stergiopoulos. Stella Stergiopoulos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Dent, Susan, Avirup Guha, Doris Makari, et al.. (2025). CARDIAC-STAR: prevalence of cardiovascular comorbidities in patients with HR + /HER2 − metastatic breast cancer. Cardio-Oncology. 11(1). 7–7.
3.
Dent, Susan, Avirup Guha, Stella Stergiopoulos, et al.. (2024). Abstract PO1-04-13: CARDIAC-STAR: Prevalence of Cardiovascular Comorbidities in Hormone Receptor Positive Human Epidermal Growth Factor Negative metaStatic breasT cAnceR. Cancer Research. 84(9_Supplement). PO1–4. 1 indexed citations
4.
Brufsky, Adam, Marilyn L. Kwan, Rickard Sandin, et al.. (2024). Trends in HR+ metastatic breast cancer survival before and after CDK4/6 inhibitor introduction in the United States: a SEER registry analysis of patients with HER2− and HER2+ metastatic breast cancer. Breast Cancer Research and Treatment. 208(2). 223–235. 2 indexed citations
5.
Stergiopoulos, Stella, et al.. (2021). Shingles vaccination uptake in Massachusetts adults aged 50 years and older. Vaccine. 39(46). 6781–6786. 11 indexed citations
6.
Stergiopoulos, Stella, et al.. (2020). Measuring the Impact of PatientEngagement and Patient Centricityin Clinical Research and Development. Therapeutic Innovation & Regulatory Science. 54(1). 103–116. 36 indexed citations
7.
Getz, Kenneth, et al.. (2020). Assessing Patient Participation Burden Based on Protocol Design Characteristics. Therapeutic Innovation & Regulatory Science. 54(3). 598–604. 3 indexed citations
8.
Stergiopoulos, Stella, et al.. (2019). Adverse Drug Reaction Case Safety Practices in Large Biopharmaceutical Organizations from 2007 to 2017: An Industry Survey. Pharmaceutical Medicine. 33(6). 499–510. 18 indexed citations
9.
DiMasi, Joseph A., et al.. (2019). Development Times and Approval Success Rates for Drugs to Treat Infectious Diseases. Clinical Pharmacology & Therapeutics. 107(2). 324–332. 16 indexed citations
10.
Stergiopoulos, Stella, et al.. (2018). Evaluating the Completeness of ClinicalTrials.gov. Therapeutic Innovation & Regulatory Science. 53(3). 307–317. 27 indexed citations
11.
Getz, Kenneth, et al.. (2017). Baseline Assessment of a Global Clinical Investigator Landscape Poised for Structural Change. Therapeutic Innovation & Regulatory Science. 51(5). 575–581. 7 indexed citations
12.
Getz, Kenneth, et al.. (2016). The Impact of Protocol Amendments on Clinical Trial Performance and Cost. Therapeutic Innovation & Regulatory Science. 50(4). 436–441. 32 indexed citations
13.
Stergiopoulos, Stella, et al.. (2016). Mobile Nurse Services in Clinical Trials: Usage and Industry Perceptions. Therapeutic Innovation & Regulatory Science. 50(4). 442–449. 3 indexed citations
14.
Stergiopoulos, Stella, et al.. (2016). A Survey of Adverse Event Reporting Practices Among US Healthcare Professionals. Drug Safety. 39(11). 1117–1127. 43 indexed citations
15.
Stergiopoulos, Stella & Kenneth Getz. (2015). Evaluating AE Reporting of Two Off-Patent Biologics to Inform Future Biosimilar Naming and Reporting Practices. Drug Safety. 38(8). 687–692. 2 indexed citations
16.
Stergiopoulos, Stella, et al.. (2015). Identifying and Quantifying the Accuracy of Product Name Attribution of US-Sourced Adverse Event Reports in MedWatch of Somatropins and Insulins. Therapeutic Innovation & Regulatory Science. 49(5). 706–716. 6 indexed citations
17.
Naik, Paulami, et al.. (2015). Regulatory Definitions and Good Pharmacovigilance Practices in Social Media: Challenges and Recommendations. Therapeutic Innovation & Regulatory Science. 49(6). 840–851. 6 indexed citations
18.
Getz, Kenneth, et al.. (2013). Quantifying the Magnitude and Cost of Collecting Extraneous Protocol Data. American Journal of Therapeutics. 22(2). 117–124. 31 indexed citations
19.
Getz, Kenneth, Jennifer Kim, Stella Stergiopoulos, & Kenneth I. Kaitin. (2013). New Governance Mechanisms to Optimize Protocol Design. Therapeutic Innovation & Regulatory Science. 47(6). 651–655. 9 indexed citations
20.
Getz, Kenneth, Stella Stergiopoulos, & Kenneth I. Kaitin. (2012). Evaluating the Completeness and Accuracy of MedWatch Data. American Journal of Therapeutics. 21(6). 442–446. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alexandra Păcurariu Breakdown of academic impact, for papers by Tiffany S. Woodworth Breakdown of academic impact, for papers by Susan Andrade Breakdown of academic impact, for papers by Alex Asiimwe Breakdown of academic impact, for papers by Ana Hidalgo‐Simon Breakdown of academic impact, for papers by Stephanie D. Schech Breakdown of academic impact, for papers by F. Maignen Breakdown of academic impact, for papers by Janet Marchibroda Breakdown of academic impact, for papers by Arun Bhatt Breakdown of academic impact, for papers by Aarthi Iyer
Rankless by CCL
2026